The purpose of this study is to determine whether Nuedexta is effective in the treatment of
symptoms (impaired speech, swallowing, and saliva control)associated with Amyotrophic Lateral
Sclerosis (ALS).
Phase:
Phase 2
Details
Lead Sponsor:
Center for Neurologic Study, La Jolla, California,
Collaborators:
ALS Association State University of New York - Upstate Medical University